Compare Centene Corp (CNC) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Taskus Inc — how do they compare? Centene Corp trades at $66.5 (market cap $33.93B), while Taskus Inc trades at $5.61 (market cap $530.70M). The key difference: Centene Corp is far larger — about 63.9× Taskus Inc's market cap, and Centene Corp is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| CNC | TASK | |
|---|---|---|
Market Cap | $33.93B | $530.70M |
Sector | Health | Technology |
52-Week High | $68.72 | $18.21 |
52-Week Low | $25.21 | $4.57 |
Enterprise Value | $26.56B | $926.40M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
TaskUs (TASK) trades at $5.62, up 3.88% with strong valuation metrics including P/E of 4.97 and P/S of 0.43. The company reported Q1 2026 earnings miss but maintains solid fundamentals with 8.7% net margin and 26.52% ROE. Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages. Recent CFO appointment and robotaxi survey highlight growth initiatives.
The stock appears undervalued with 69% upside to consensus target of $9.50. Strong cash flow generation and improving debt-to-asset ratio (22.96% in 2025) support bullish case. Risks include competitive pressures and earnings volatility. Analyst consensus leans bullish with 55% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
